Disclosure of directors' and officers' relevant interests
|
|
Life Pharmacy Limited (LPL) | 3:32 pm, Friday 29 August 2008 | LPL | 0.460 |
 0 |
(+0.00%) |
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Brian Philip Ingham
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Director
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Brian Philip Ingham
Class and type of security (as required by regulation 6B or
regulation 8) Ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Registered holder and beneficial owner
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 28 August
2007
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 21 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Transfer of ordinary shares from Life Pharmacy Trustee Company Limited
Consideration (as required by regulation 10) Nil
Number of securities held prior, set out by class and type (as
required by regulation 8) 234,000 ordinary shares, 900,000 partly paid
redeemable ordinary shares and an option to acquire 1,000,000 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 480 ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 234,480 ordinary shares, 900,000 partly
paid redeemable ordinary shares and an option to acquire 1,000,000 ordinary
shares
G Signature
Signature (as required by regulation 14)
